Home › NDC Lookup › RxCUI directory › RxCUI 2045493

Fingolimod 0.25 MG Oral Capsule [Gilenya] — RxCUI 2045493

RxNorm drug concept · Semantic branded drug
RxCUI 2045493 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2045493
Official nameFingolimod 0.25 MG Oral Capsule [Gilenya]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asGilenya 0.25 MG Oral Capsule; Gilenya 0.25 MG (as fingolimod HCl 0.28 MG) Oral Capsule
FDA products mapped2
Package NDCs mapped2
Reported Medicaid activity (SDUD)1,625 prescriptions · 14 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Fingolimod: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Fingolimod works by keeping certain immune cells — the ones that damage your nerves — locked inside your lymph nodes so they can't travel to your brain or spinal cord. This reduces...
  • What exactly is fingolimod doing for my MS?
  • Fingolimod slows your heart rate — especially after that very first dose. The drop can be significant in the first few hours, and in some people it can cause symptoms like dizzines...
  • Why do I have to be monitored for hours after my first dose?
📖 Read our full Fingolimod guide →

🕸️ Concept Web — How Fingolimod 0.25 MG Oral Capsule [Gilenya] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Fingolimod 0.25 MG Oral Capsule [Gilenya] RxCUI 2045493

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Fingolimod 1012892
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Gilenya 1012896
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Fingolimod Oral Capsule 1012894
    • Fingolimod Oral Product 1165017
    • Fingolimod Pill 1165018
    • Fingolimod Oral Capsule [Gilenya] 1012898
    • Gilenya Oral Product 1170524
    • Gilenya Pill 1170525
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Fingolimod 0.25 MG Oral Capsule SCD · 2045491
  • Fingolimod 0.25 MG SCDC · 2045490
  • Fingolimod Oral Capsule SCDF · 1012894
  • Fingolimod Oral Product SCDG · 1165017
  • Fingolimod Pill SCDG · 1165018

Brand-Name Concepts

  • Fingolimod 0.25 MG [Gilenya] SBDC · 2045492
  • Fingolimod Oral Capsule [Gilenya] SBDF · 1012898
  • Gilenya Oral Product SBDG · 1170524
  • Gilenya Pill SBDG · 1170525
  • Gilenya BN · 1012896

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 2045493 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00078-0607-15 30 CAPSULE in 1 BOTTLE (0078-0607-15) Gilenya Novartis Pharmaceuticals Corporation 2010-09-21
00078-0965-89 7 CAPSULE in 1 CARTON (0078-0965-89) Gilenya Novartis Pharmaceuticals Corporation 2018-05-11
Observed labelers: Novartis Pharmaceuticals Corporation (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.